SUMMARY Spontaneous and mutagen induced sister chromatid exchange (SCE) frequencies have been studied in nine patients with multiple sclerosis and in nine age and sex matched healthy controls. The incidence of spontaneous SCE in lymphocytes of the MS patients was significantly greater, by about 50 %, than in those of the control subjects. When exposed to mitomycin C (MMC) or ethyl methane sulfonate (EMS) in vitro, cells from both groups showed typical dose dependent increases in SCE frequency, with yields from MS patients slightly higher than from controls. The higher SCE yields in mutagen treated MS cells relative to controls is considered to reflect initial basal differences between the cell types, so that MS cells are not intrinsically hypersensitive to mutagen treatment.
Multiple sclerosis (MS) is a common disease of the nervous system affecting about 50 000 people in the United Kingdom. The highest prevalance of MS in the world is in the Orkney and Shetland Isles.' The onset of the disease is usually between 15 and 50 years of age and the incidence in females outnumbers that in males by 1 4:1. The disease has been recognised for the past century but the exact cause is still unknown. Investigations on histocompatibility antigens2-4 and family studies showing that about 10% of patients with MS have an affected relative5 reveal an influence of genetic factors associated with the susceptibility to the disease, and epidemiological studies point to the possible role of viral infection. 6 Many other correlations implicating diet7 and geoclimatic and socioeconomic variables5 8 18 We have examined this possibility and in the present paper report on the incidence of spontaneous and mutagen induced SCE in the lymphocytes of nine MS patients and matched controls and conclude that MS is not associated with mutagen hypersensitivity.
Materials and methods
The nine patients studied, four males and five females, were unrelated and their ages ranged from 25 to 56 years (mean 41 years). All of the patients satisfied the criteria described by McDonald and 372 Halliday19 of clinically definite multiple sclerosis. Symptoms had been present for from 3 to 27 years (mean 10 years) at the time of blood sampling, two of the patients had been treated with antibiotics and analgesics not known to cause chromosome damage, and one had completed a three day course on dexamethasone just before study. Heparinised whole blood was collected from the nine patients and from an equal number of age and sex matched healthy controls. From each subject, separate cultures were set up each using 0 8 ml blood in 10 ml RPMI 1640 medium containing 20% fetal calf serum, 1 % PHA (Wellcome), 1 % glutamine, 100 U penicillin, 100 ,ug streptomycin, and 25 ,umol/l BrdU. Mitomycin C (MMC, Kyowa, Japan) dissolved in distilled water was immediately added to one set of cultures to give final concentrations of 10-8, 3 x 10-8, and 10-7 mol/l. Ethylmethanesulfonate (EMS, Koch-Light Laboratories) dissolved in distilled water was added to a second set of cultures to give final concentrations of 10-4, 3 x 10-4, and 10-3 mol/l. All cultures were kept in the dark at 37°C for 72 hours and were treated with 5 x 10-7 mol/l colchicine for the last 2 hours. The cells were then collected, treated with 75 mmol/l potassium chloride for 8 minutes, fixed in 3:1 methanol acetic acid mixture, and dropped onto slides which were air dried. The higher than in cells from controls. However, the dose response curves for MS cells are parallel to those of control cells, so that the difference between these two groups is simply a reflection of their basal differences in SCE incidence and is not a consequence of any differential sensitivity to the mutagens. Our findings therefore do not support the suggestion of possible anomalies in DNA repair in MS patients.17
In conclusion, our evidence would suggest that the enhanced basal SCE frequency in MS lymphocytes is a consistent finding which, on the basis of the mutagen experiments, does not appear to be a consequence of mutagen hypersensitivity associated with abnormal DNA repair. This enhancement would appear to be associated with alterations in lymphocyte population structure, but whether these alterations are themselves a consequence of viral infection remains to be established, and the possibility that the raised SCE incidence is, at least in part, directly rather than indirectly associated with virus infection cannot be discounted. 
